Hypoxic signaling is also disrupted by loss-of-function mutations in VHL, which cause von Hippel-Lindau disease, a syndrome characterized by tumors in several organs, including kidney, central nervous system, pancreas and adrenal gland. This evidence concerns the gene VHL and von Hippel-Lindau disease.